Nrx Pharmaceuticals Stock Buy Hold or Sell Recommendation
| NRXP Stock | USD 3.12 0.07 2.30% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding NRX Pharmaceuticals is 'Strong Sell'. Macroaxis provides NRX Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NRXP positions. The advice algorithm takes into account all of NRX Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting NRX Pharmaceuticals' buy or sell advice are summarized below:
Real Value 3.04 | Target Price 3.08 | Hype Value 3.09 | Market Value 3.12 | Naive Value 2.15 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell NRX Pharmaceuticals given historical horizon and risk tolerance towards NRX Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for NRX Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
NRX |
Execute NRX Pharmaceuticals Buy or Sell Advice
The NRX recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on NRX Pharmaceuticals. Macroaxis does not own or have any residual interests in NRX Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute NRX Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
NRX Pharmaceuticals Trading Alerts and Improvement Suggestions
| NRX Pharmaceuticals had very high historical volatility over the last 90 days | |
| NRX Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NRX Pharmaceuticals currently holds about 24.55 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| NRX Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 162500 shares by Van Voorhees Seth of NRX Pharmaceuticals at 0.514 subject to Rule 16b-3 |
NRX Pharmaceuticals Returns Distribution Density
The distribution of NRX Pharmaceuticals' historical returns is an attempt to chart the uncertainty of NRX Pharmaceuticals' future price movements. The chart of the probability distribution of NRX Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use NRX Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of NRX Pharmaceuticals returns is essential to provide solid investment advice for NRX Pharmaceuticals.
| Mean Return | 0.06 | Value At Risk | -12.24 | Potential Upside | 17.70 | Standard Deviation | 10.33 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of NRX Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
NRX Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as NRX Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NRX Pharmaceuticals backward and forwards among themselves. NRX Pharmaceuticals' institutional investor refers to the entity that pools money to purchase NRX Pharmaceuticals' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2023-12-31 | 46.8 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 44.3 K | Charles Schwab Investment Management Inc | 2023-12-31 | 43.7 K | Highpoint Advisor Group Llc | 2023-12-31 | 43.5 K | Hbk Sorce Advisory Llc | 2023-12-31 | 29.2 K | Tower Research Capital Llc | 2023-12-31 | 19.7 K | Group One Trading, Lp | 2023-12-31 | 19.2 K | United Asset Strategies Inc | 2023-12-31 | 18.3 K | Jpmorgan Chase & Co | 2023-12-31 | 16.8 K | Vanguard Group Inc | 2023-12-31 | 1.4 M | Advisorshares Investments, Llc | 2023-12-31 | 642.6 K |
NRX Pharmaceuticals Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (11.1K) | 982K | 25.7M | (7.6M) | (15.5M) | (14.7M) | |
| Free Cash Flow | (792.7K) | (2.3M) | (37.7M) | (39.8M) | (21.7M) | (22.7M) | |
| Other Non Cash Items | (1.3M) | 39.6M | 54.3M | (4.3M) | 5.6M | 5.3M | |
| Capital Expenditures | 3.55 | 2K | 7K | 10K | 3K | 3.5K | |
| Net Income | 408.4K | (51.8M) | (93.1M) | (39.8M) | (30.2M) | (31.7M) | |
| End Period Cash Flow | 6.0 | 1.9M | 27.6M | 20.1M | 4.6M | 8.6M |
NRX Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to NRX Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that NRX Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a NRX stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.14 | |
β | Beta against NYSE Composite | -1.03 | |
σ | Overall volatility | 10.47 | |
Ir | Information ratio | -0.0031 |
NRX Pharmaceuticals Volatility Alert
NRX Pharmaceuticals is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure NRX Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact NRX Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.NRX Pharmaceuticals Fundamentals Vs Peers
Comparing NRX Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze NRX Pharmaceuticals' direct or indirect competition across all of the common fundamentals between NRX Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as NRX Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of NRX Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing NRX Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare NRX Pharmaceuticals to competition |
| Fundamentals | NRX Pharmaceuticals | Peer Average |
| Return On Equity | -6.83 | -0.31 |
| Return On Asset | -1.04 | -0.14 |
| Current Valuation | 33.38 M | 16.62 B |
| Shares Outstanding | 10.49 M | 571.82 M |
| Shares Owned By Insiders | 27.41 % | 10.09 % |
| Shares Owned By Institutions | 3.91 % | 39.21 % |
| Number Of Shares Shorted | 4.25 M | 4.71 M |
| Price To Book | 6.95 X | 9.51 X |
| EBITDA | (27.58 M) | 3.9 B |
| Net Income | (30.15 M) | 570.98 M |
| Cash And Equivalents | 24.55 M | 2.7 B |
| Cash Per Share | 0.36 X | 5.01 X |
| Total Debt | 9.16 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 4.58 X | 2.16 X |
| Book Value Per Share | (1.42) X | 1.93 K |
| Cash Flow From Operations | (21.66 M) | 971.22 M |
| Short Ratio | 1.55 X | 4.00 X |
| Earnings Per Share | (4.00) X | 3.12 X |
| Target Price | 31.67 | |
| Beta | 1.03 | -0.15 |
| Market Capitalization | 31.99 M | 19.03 B |
| Total Asset | 7.32 M | 29.47 B |
| Retained Earnings | (253.15 M) | 9.33 B |
| Working Capital | (12.16 M) | 1.48 B |
| Net Asset | 7.32 M |
Note: Disposition of 162500 shares by Van Voorhees Seth of NRX Pharmaceuticals at 0.514 subject to Rule 16b-3 [view details]
NRX Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NRX . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 3.12 | |||
| Day Typical Price | 3.12 | |||
| Price Action Indicator | 0.035 | |||
| Period Momentum Indicator | 0.07 | |||
| Relative Strength Index | 47.39 |
About NRX Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell NRX Pharmaceuticals? Buying financial instruments such as NRX Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 4.9M | 5.8M | 5.3M | 9.2M | Total Assets | 32.7M | 25.8M | 7.3M | 6.9M |
Use Investing Ideas to Build Portfolios
In addition to having NRX Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Shipping Containers Thematic Idea Now
Shipping Containers
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipping Containers theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipping Containers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out NRX Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for NRX Stock analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is NRX Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NRX Pharmaceuticals. If investors know NRX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NRX Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.00) | Return On Assets (1.04) | Return On Equity (6.83) |
The market value of NRX Pharmaceuticals is measured differently than its book value, which is the value of NRX that is recorded on the company's balance sheet. Investors also form their own opinion of NRX Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NRX Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NRX Pharmaceuticals' market value can be influenced by many factors that don't directly affect NRX Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NRX Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NRX Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NRX Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.